Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 281-300 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 281 | Beyond Gravity lowweak | Opp 1 Risk 1 | Thesis: No positive thesis can be supported from these reviewed sources because no direct positive evidence survived the 90-day recent evidence window. Why now: There is no within the recent evidence window evidence in the reviewed sources for a current catalyst or state change; recency support is absent. Caveats: The reviewed sources show 8 articles were considered but 0 article IDs remained after recent evidence filtering. Phase-2 membership rationale references: but no article summary or is provided in these reviewed sources, so it cannot be cited as factual support. Scores are kept near zero because direction must come from structured polarity/materiality evidence, which is absent. |
| 282 | Blackstar Orbital lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources offers only relation-style context and no direct positive evidence, so there is no supportable opportunity thesis. Why now: Membership rationale says Starfighters Space expanded technical interchange with Blackstar Orbital (SpaceDrone) in article: but relations are context only and no or direct evidence are provided. Caveats: Relations marked context-only cannot be used as counterparty propagation evidence. No post-recent evidence window evidence are available. Referenced: has no in the reviewed sources. |
| 283 | Canada Rocket Company lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources indicates membership support that Canada Rocket Company was identified as one of three Canadian rocket startups receiving government funding, but no within the recent evidence window direct positive evidence or article summaries are available for scoring, so opportunity evidence is too thin to form a positive thesis from these reviewed sources alone. Why now: No dated within the recent evidence window scoring evidence is available. The reviewed sources show zero reviewed evidence after recent evidence filtering, so recency-sensitive judgment is not possible from this screen. Caveats: Phase-2 membership rationale references support article: but the article summary and evidence are not available here, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Absence of negative evidence is not positive evidence. |
| 284 | Canon Inc. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources contain no direct positive evidence for Canon within the scoring window. The membership rationale says Canon is mentioned only as one of Rocket Lab's partners/customers in a CubeSat article, which is too incidental to support a company-level opportunity thesis. Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 863 article IDs considered but 0 after recent evidence window and 0 evidence available after dedupe. Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Described relevance is only incidental counterparty/customer context. |
| 285 | Capella Space lowweak | Opp 1 Risk 1 | Thesis: This reviewed sources slice references only competitive landscape and generic market-report mentions in the phase-2 rationale, with no retained direct positive evidence in the recent evidence window, so there is not enough support for a positive thesis. Why now: Why now is weak because only 2 articles were considered and none remained after the 90-day recent evidence window; current business-state evidence is absent. Caveats: Duplicate/slice limitation noted in phase-2 rationale. No recent evidence window-qualified direct evidence. This reviewed sources specifically warns stronger Capella evidence may exist elsewhere, but it is not in this local reviewed sources and cannot be used. |
| 286 | Casimir Inc. lowweak | Opp 1 Risk 2 | Thesis: The only possible positive read is from the phase2 rationale, which says Casimir raised a $12M seed round and is tied to a NASA-veteran founder. If accurate, recent financing could support development over a 1 year+ horizon, but the reviewed sources does not include a citable article /summary and also notes the business described is quantum vacuum energy chips rather than a clearly defined target space operating category. Why now: There is no available article summary or evidence row after recent evidence window, so the only 'why now' is the uncitable phase2 statement about a seed round referenced by article id: without. Caveats: The reviewed sources itself says the support article is blog commentary, weakening source quality. No citable or summary is provided for the referenced article id No evidence were available after recent evidence window in the served reviewed sources. |
| 287 | China Aerospace Science and Technology Corporation lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not load any direct positive evidence within the 90-day recent evidence window, so no positive thesis is supported. Why now: No current ranking evidence is available: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites contextual mention of CASC via article, but unavailable in reviewed sources. Caveats: Only contextual mention is described in membership rationale. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources. |
| 288 | China Rocket lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not retain sufficient direct positive evidence for a durable opportunity thesis. Why now: The membership rationale says Jielong 3 is by CASC subsidiary China Rocket and cites article, but support is described as only a brief article-context mention and no retained evidence row or is provided after recent evidence window. Caveats: Support is explicitly called provisional single-article context in the reviewed sources. No retained evidence are available. |
| 289 | China Spacesat lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only says an opinion piece listed China Spacesat among global space companies, with no direct facts or events specific to the company retained after recent evidence window, so there is no evidence basis for a positive thesis. Why now: No within the recent evidence window catalyst or business-state change is documented. The reviewed sources show zero retained evidence after recent evidence window. Caveats: Phase-2 rationale references: but no or retained article summary is provided. Support is described as provisional single-article context only. Coverage debug shows no retained evidence. |
| 290 | Chunghwa Telecom Co., Ltd. lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supportable from the retained reviewed sources evidence because there is no direct positive evidence after recent evidence window. Why now: Why now is weak: the reviewed sources show zero retained evidence after recent evidence window, so there is no current catalyst or business-state confirmation in the evidence provided. Caveats: Phase-2 membership rationale references: and says Astranis has new satellite projects with Chunghwa Telecom launching later in 2026, but no article summary or retained quoted evidence is included here, and relations are context-only unless separately policy-gated. Coverage after recent evidence window is empty for this company. |
| 291 | Clear Space lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only indicates that Clear Space develops space lidars in a space or aerospace context. That is not enough to support a meaningful positive thesis over a 1 year+ horizon without current financing, contracts, or milestone evidence. Why now: There is no strong why-now support because no evidence were available after recent evidence window; current operating or financing status is unconfirmed in the reviewed sources. Caveats: No in-window evidence are available. Membership rationale itself notes the evidence is sparse and does not explicitly establish on-orbit servicing in these reviewed sources. Recency is unconfirmed. |
| 292 | Collins lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources notes many mentions tied mainly to RTX/Raytheon and market lists, but does not cleanly establish 'Collins' as a target company with direct positive business evidence in the recent evidence window. Why now: There is no usable timing evidence. Despite large article count, coverage data shows 0 articles after recent evidence window and 0 evidence after recent evidence window, and no are provided for cited support article ids or. Caveats: High mention volume is not conviction and cannot substitute for company-specific evidence. The reviewed sources itself flags insufficiently established entity identity and role. No representative articles or are available for citation despite many articles considered. |
| 293 | Comtech Telecommunications Corp. lowweak | Opp 1 Risk 1 | Thesis: No positive thesis can be supported from these reviewed sources because no direct positive evidence or representative article summaries are provided within the recent evidence window. Why now: There is no usable company-specific evidence in the reviewed sources after recent evidence filtering; coverage data shows zero article IDs after recent evidence window and zero evidence available, so there is no current catalyst basis in these reviewed sources. Caveats: Absence of evidence is not positive evidence. Reviewed evidence notes only weak peer-group context in phase2 rationale, but no citable article details are included in the scoring fields. |
| 294 | Cosmoserve lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources rationale weakly suggests possible opportunity because Cosmoserve is mentioned among Indian space-tech startups and the article notes product-technologies including satellite communications. But the reviewed sources does not directly describe Cosmoserve's own business or provide a citable article summary/ in the recent evidence window. Why now: No in-recent evidence window article summary or evidence row was available for Cosmoserve, so there is no supported catalyst timing. Caveats: The mention is article-level and indirect rather than company-specific. Phase2 rationale references article id: but no or summary is included. No direct evidence were available after recent evidence window. |
| 295 | Cosmoserve Space lowweak | Opp 1 Risk 1 | Thesis: The company is described in membership rationale as participating in debris removal and RPOD-related activity, but no retained 90-day direct positive evidence supports a forward opportunity thesis. Why now: The reviewed sources retains zero evidence after the recent evidence filter, leaving no current catalyst or recency-supported business update. Caveats: Only one historical article was considered and none are retained within the recent evidence window. The single membership support item is not enough for a current directional call. This is effectively a watchlist placeholder until newer evidence appears. |
| 296 | Digantara lowweak | Opp 1 Risk 1 | Thesis: The membership rationale suggests funding and space situational awareness relevance, but the served reviewed sources retains no 90-day positive evidence to support a long-horizon opportunity thesis. Why now: Despite several historical mentions, the reviewed sources show zero retained article IDs and zero evidence after recent evidence filtering, so there is no recent catalyst evidence in the served data. Caveats: Historical support mentions approximately $50M funding, but the underlying evidence is not retained within the current recent evidence window reviewed sources. Low scores reflect missing current evidence, not a negative operating judgment. |
| 297 | Digantara lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources indicates Digantara is relevant to space situational awareness and references a missile tracking satellite, which could imply strategic relevance, but there is no usable in-window article or evidence available for directional scoring. Why now: There is no strong 'why now' because coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any thesis would be under-supported for current timing. Caveats: No evidence remained after the 90-day recent evidence window. Phase-2 membership rationale is not enough for a directional thesis by itself. Recency and business-state claims are unavailable in the reviewed sources. |
| 298 | DPhi Space lowweak | Opp 1 Risk 1 | Thesis: Only a minimal opportunity view is possible because the phase2 rationale says DPhi Space was using Solstar's Deke system and was identified as Swiss, implying some active space-company involvement. But the reviewed sources explicitly says the business fit remains indirect and thin. Why now: No available article summaries or evidence exist after recent evidence window for DPhi Space in these reviewed sources, so there is no supported why-now catalyst. Caveats: Support level is only provisional_single_article_context in the reviewed sources. Phase2 rationale references article id, but no or summary is included. No evidence were available after recent evidence window. |
| 299 | EarthDaily lowweak | Opp 1 Risk 2 | Thesis: The reviewed sources membership rationale says EarthDaily received an NRO contract for EO/IR under Strategic Commercial Enhancements, which could support a long-horizon government-demand opportunity, but no within the recent evidence window evidence or article details were available to substantiate the claim for ranking use in this screen. Why now: Why now is weak because the reviewed sources show zero evidence kept within the 90-day recent evidence window for ranking, making recency and business-state assessment uncertain. Caveats: Phase-2 membership rationale references: but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Cannot treat cohort membership as thesis attractiveness. |
| 300 | Elbit Systems Ltd. lowweak | Opp 1 Risk 1 | Thesis: Despite broad defense and space-adjacent relevance in the membership rationale, the reviewed sources have no direct positive evidence within the recent evidence window, so no positive 1 year+ thesis is supportable. Why now: Membership rationale references articles: and, but coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources. Caveats: Large mention volume is not conviction. Defense-space context is not directional proof. Referenced have no in the reviewed sources. |
Risk view
Showing rows 261-280 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 261 | Axiom Space lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is present in the reviewed sources. Risk score remains low because absence of current evidence is not itself a negative thesis. Why now: There is no within the recent evidence window catalyst in the available evidence. The only cited context is an older article with September 2, 2025, outside the 90-day evidence window Caveats: Coverage after recent evidence window is effectively empty: evidence after recent evidence window is 0. Older supporting context exists but was excluded by the 90-day recent evidence window. No direct positive or negative evidence is available. |
| 262 | Axiom Space Inc. lowweak | Opp 1 Risk 1 | Thesis: No material risk thesis is supportable because the reviewed sources provide no direct negative evidence in the final evidence fields. Why now: The phase2 rationale says Axiom was mentioned in connection with a lunar suit presentation and an orbital data center feature, but those article details are not surfaced in citable evidence here. Coverage data shows zero articles after recent evidence window and zero available evidence, so there is no current catalyst basis in the reviewed sources. Caveats: Phase2 rationale is weaker than direct event/fact evidence. No dated current-state evidence is available in the scoring fields. |
| 263 | BAE Systems plc lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available for BAE Systems in this screen. Risk score stays low only because evidence is missing, not because the company is affirmatively de-risked. Why now: Why-now is weak because the reviewed sources show no reviewed evidence after recent evidence window despite many articles considered, leaving no admissible dated evidence in the current output batch. Caveats: Membership rationale references, and, but no article summaries or evidence are provided here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Broad-company membership in a cohort is not itself a directional opportunity thesis. |
| 264 | Baykar lowweak | Opp 1 Risk 1 | Thesis: No material negative thesis is supportable because the retained reviewed sources provide no direct negative evidence within the recent evidence window. Why now: Why now is weak: there are no retained evidence after recent evidence window, and the reviewed sources' membership rationale is based only on weak indirect article context. Caveats: Phase-2 membership rationale cites and says Fergani Space was described as 'Baykar affiliated,' but no article summary or quote is available in the retained reviewed sources for factual use here. The reviewed sources itself characterizes the evidence as weak, indirect article context. |
| 265 | Beyond Gravity lowweak | Opp 1 Risk 1 | Thesis: No material risk thesis can be supported from these reviewed sources because no direct negative evidence survived the 90-day recent evidence window. Why now: There is no within the recent evidence window evidence in the reviewed sources for a current catalyst or state change; recency support is absent. Caveats: The reviewed sources show 8 articles were considered but 0 article IDs remained after recent evidence filtering. Phase-2 membership rationale references: but no article summary or is provided in these reviewed sources, so it cannot be cited as factual support. Scores are kept near zero because direction must come from structured polarity/materiality evidence, which is absent. |
| 266 | Blackstar Orbital lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources offers no direct negative evidence, so there is no supportable risk thesis. Why now: Membership rationale says Starfighters Space expanded technical interchange with Blackstar Orbital (SpaceDrone) in article: but relations are context only and no or direct evidence are provided. Caveats: Relations marked context-only cannot be used as counterparty propagation evidence. No post-recent evidence window evidence are available. Referenced: has no in the reviewed sources. |
| 267 | Bluestaq lowweak | Opp 0 Risk 1 | Thesis: No material adverse evidence is shown either. The low risk score reflects absence of documented negative evidence, but the company remains unrankable on fundamentals from these reviewed sources. Why now: There is no clear why-now catalyst because the only reference is an indirect executive-background mention, with no direct event, product, contract, or financing evidence available. Caveats: No current evidence is provided for Indirect mention via an executive's prior role is not direct company evidence. Zero evidence available after recent evidence window. |
| 268 | BULL Co., Ltd. lowweak | Opp 2 Risk 1 | Thesis: No retained within the recent evidence window direct negative evidence is provided. Why now: No within the recent evidence window evidence were retained, so there is no strong timing signal for a 1 year+ ranking beyond weak membership context. Caveats: Membership rationale references articles and, but the reviewed sources does not provide or retained evidence. Potential commercial significance cannot be sized from the reviewed sources. |
| 269 | Calian Group Ltd. lowweak | Opp 2 Risk 1 | Thesis: No direct negative evidence is available, so there is no supported adverse thesis beyond normal uncertainty from lack of recent evidence. Why now: Why now is weak because the reviewed sources retained no evidence after recent evidence window for Calian, so no current catalyst is evidenced. Caveats: Reviewed evidence mentions: but provides no, preventing direct citation as scored evidence. No retained 90-day evidence. Opportunity case depends on uncited older context rather than current business-state confirmation. |
| 270 | Canada Rocket Company lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources within the recent evidence window, so there is no supported negative thesis beyond generic execution risk, which cannot be used without company-specific evidence. Why now: No dated within the recent evidence window scoring evidence is available. The reviewed sources show zero reviewed evidence after recent evidence filtering, so recency-sensitive judgment is not possible from this screen. Caveats: Phase-2 membership rationale references support article: but the article summary and evidence are not available here, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Absence of negative evidence is not positive evidence. |
| 271 | Canon Inc. lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is available, so there is no reviewed sources basis for a material risk thesis. Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 863 article IDs considered but 0 after recent evidence window and 0 evidence available after dedupe. Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Described relevance is only incidental counterparty/customer context. |
| 272 | Capella Space lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is retained either, so a risk thesis is not supported on this slice. Why now: Why now is weak because only 2 articles were considered and none remained after the 90-day recent evidence window; current business-state evidence is absent. Caveats: Duplicate/slice limitation noted in phase-2 rationale. No recent evidence window-qualified direct evidence. This reviewed sources specifically warns stronger Capella evidence may exist elsewhere, but it is not in this local reviewed sources and cannot be used. |
| 273 | China Aerospace Science and Technology Corporation lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not load any direct negative evidence within the 90-day recent evidence window, so no risk thesis is supported. Why now: No current ranking evidence is available: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites contextual mention of CASC via article, but unavailable in reviewed sources. Caveats: Only contextual mention is described in membership rationale. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources. |
| 274 | China Rocket lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not retain sufficient direct negative evidence for a risk thesis. Why now: The membership rationale says Jielong 3 is by CASC subsidiary China Rocket and cites article, but support is described as only a brief article-context mention and no retained evidence row or is provided after recent evidence window. Caveats: Support is explicitly called provisional single-article context in the reviewed sources. No retained evidence are available. |
| 275 | China Spacesat lowweak | Opp 1 Risk 1 | Thesis: There is no retained adverse evidence specific to China Spacesat, so a risk thesis is unsupported. Why now: No within the recent evidence window catalyst or business-state change is documented. The reviewed sources show zero retained evidence after recent evidence window. Caveats: Phase-2 rationale references: but no or retained article summary is provided. Support is described as provisional single-article context only. Coverage debug shows no retained evidence. |
| 276 | Chunghwa Telecom Co., Ltd. lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supportable from the retained reviewed sources evidence because there is no direct negative evidence after recent evidence window. Why now: Why now is weak: the reviewed sources show zero retained evidence after recent evidence window, so there is no current catalyst or business-state confirmation in the evidence provided. Caveats: Phase-2 membership rationale references: and says Astranis has new satellite projects with Chunghwa Telecom launching later in 2026, but no article summary or retained quoted evidence is included here, and relations are context-only unless separately policy-gated. Coverage after recent evidence window is empty for this company. |
| 277 | CITIC Group lowweak | Opp 0 Risk 1 | Thesis: No material direct negative evidence is available, but ambiguity and possible spurious matching elevate watchlist risk slightly. Why now: There is no current catalyst. Despite 4,475 article IDs considered, the reviewed sources reports zero article IDs after recent evidence window and zero evidence after recent evidence window. Caveats: Phase2 rationale references article IDs: and: as context, but no were provided in the reviewed sources. Very large raw mention universe does not imply conviction or thesis attractiveness. Possible name/alias ambiguity is unresolved by the reviewed sources. |
| 278 | Citra Space Corp lowweak | Opp 2 Risk 1 | Thesis: No retained within the recent evidence window direct negative evidence is provided, so there is no basis for a strong risk thesis. Why now: There is no usable within the recent evidence window article evidence available for ranking; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any current catalyst judgment would be speculative. Caveats: Membership rationale references article, but the reviewed sources does not provide the article or retained ranking evidence inside the recent evidence window. Because direct evidence arrays are empty, the small positive score reflects only weak contextual possibility, not high-confidence attractiveness. |
| 279 | Clear Space lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is present. Ranking remains low on risk because the reviewed sources does not document a negative catalyst. Why now: There is no strong why-now support because no evidence were available after recent evidence window; current operating or financing status is unconfirmed in the reviewed sources. Caveats: No in-window evidence are available. Membership rationale itself notes the evidence is sparse and does not explicitly establish on-orbit servicing in these reviewed sources. Recency is unconfirmed. |
| 280 | Collins lowweak | Opp 1 Risk 1 | Thesis: Entity-identity ambiguity is the main risk in these reviewed sources; there is no available material adverse evidence specific to Collins after recent evidence filtering. Why now: There is no usable timing evidence. Despite large article count, coverage data shows 0 articles after recent evidence window and 0 evidence after recent evidence window, and no are provided for cited support article ids or. Caveats: High mention volume is not conviction and cannot substitute for company-specific evidence. The reviewed sources itself flags insufficiently established entity identity and role. No representative articles or are available for citation despite many articles considered. |